JHL Biotech, Inc. announced the appointment of Ellis Chu as its Chief Financial Officer, effective May 2018. Mr. Chu most recently served as a Managing Director and the Head of Greater China at Ion Pacific. Prior to Ion Pacific, Ellis spent the bulk of his career in investment banking, including serving as Head of China Mergers & Acquisitions at Bank of America Merrill Lynch.